Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.522 EUR | -3.33% | +0.77% | -26.79% |
Feb. 06 | FTSE 100 Closes Up 0.9%, Lifted by BP | DJ |
Feb. 06 | Novacyt says talks to sell Taiwan laboratory are terminated | AN |
Sales 2021 | 95.78M 104M | Sales 2022 | 21.04M 22.84M | Capitalization | 76.79M 83.36M |
---|---|---|---|---|---|
Net income 2021 | -9M -9.77M | Net income 2022 | -25M -27.14M | EV / Sales 2021 | 1.67 x |
Net cash position 2021 | 99.9M 108M | Net cash position 2022 | 86.29M 93.68M | EV / Sales 2022 | -0.45 x |
P/E ratio 2021 |
-26.3
x | P/E ratio 2022 |
-2.99
x | Employees | 120 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 96.6% |
Latest transcript on Novacyt
1 day | -1.02% | ||
1 week | +3.19% | ||
Current month | +3.79% | ||
1 month | -3.35% | ||
3 months | -28.73% | ||
6 months | -28.64% | ||
Current year | -25.04% |
Managers | Title | Age | Since |
---|---|---|---|
James McCarthy
CEO | Chief Executive Officer | 58 | 21-01-04 |
Steven Gibson
DFI | Director of Finance/CFO | 41 | 17-03-31 |
Paul Oladimeji
CTO | Chief Tech/Sci/R&D Officer | - | 16-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Heath
BRD | Director/Board Member | 76 | 15-06-28 |
John Brown
BRD | Director/Board Member | 69 | 23-09-07 |
Lyn Rees
BRD | Director/Board Member | 51 | 23-09-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-19 | 0.522 | -3.33% | 45 913 |
24-03-18 | 0.54 | -0.92% | 41,860 |
24-03-15 | 0.545 | +2.83% | 104,881 |
24-03-14 | 0.53 | 0.00% | 32,160 |
24-03-13 | 0.53 | +2.32% | 65,143 |
Real-time Euronext Paris, March 19, 2024 at 04:03 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.04% | 41.42M | |
+10.93% | 1.09B | |
-18.94% | 134M | |
+30.54% | 69.66M | |
+7.18% | 62.68M | |
+13.27% | 61.72M | |
-20.97% | 57.84M |